Since joining Pfizer in 2009 as head of Global Benefits, Steve has led efforts to ensure that Pfizer colleagues have access to comprehensive, high-quality healthcare benefits. He and his team have developed partnerships with health plans and health innovators to put in place programs that best meet the needs of Pfizer’s population. Steve has been a member of NEBGH’s board of directors since 2009 and serves on the board’s Executive Committee as well. As a board member, Steve has been instrumental in setting strategic direction for NEBGH.

Steve joined Pfizer through the acquisition of Wyeth. He is an actuary and has worked for both Watson Wyatt (now Willis Towers Watson) and Hewitt (now Aon).